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Background: Medullary nephrocalcinosis and distal renal tubular acidosis are closely associated and each can lead
to the other. These clinical entities are rare in patients with nephrotic syndrome and polycythaemia is an unusual
finding in such patients. We describe the presence of medullary nephrocalcinosis, distal renal tubular acidosis and
polycythaemia in a patient with nephrotic syndrome due to minimal change disease. Proposed mechanisms of
polycythaemia in patients with nephrotic syndrome and distal renal tubular acidosis include, increased
erythropoietin production and secretion of interleukin 8 which in turn stimulate erythropoiesis.
Case presentation: A 22 year old Sri Lankan Sinhala male with nephrotic syndrome due to minimal change disease
was investigated for incidentally detected polycythaemia. Investigations revealed the presence of renal tubular acidosis
type I and medullary nephrocalcinosis. Despite extensive investigation, a definite cause for polycythaemia was not
found in this patient. Treatment with potassium and bicarbonate supplementation with potassium citrate led to
correction of acidosis thereby avoiding the progression of nephrocalcinosis and harmful effects of chronic acidosis.
Conclusion: The constellation of clinical and biochemical findings in this patient is unique but the pathogenesis of
erythrocytosis is not clearly explained. The proposed mechanisms for erythrocytosis in other patients with proteinuria
include increased erythropoietin secretion due to renal hypoxia and increased secretion of interleukin 8 from the
kidney. This case illustrates that there may exist hitherto unknown connections between tubular and glomerular
dysfunction in patients with nephrotic syndrome.
Keywords: Medullary nephrocalcinosis, Nephrotic syndrome, Polycythaemia, Renal tubular acidosis type IBackground
Childhood nephrotic syndrome with bland urinary sedi-
ment is usually managed as minimal change disease and
renal biopsy is not necessary for the diagnosis unless
there are unusual features [1]. Although some children
achieve a sustained remission or reduced frequency of
relapses as they grow older, others tend to have repeated
relapses during young adulthood.
Distal renal tubular acidosis is due to defective proton
secretion from the alpha (α) intercalated cells of the distal
tubule caused by dysfunction of the H+/K+ antiporter on
the apical membrane [2]. This leads to failure of H+ excre-
tion thereby causing systemic acidosis and potassium
depletion. Inability to lower the urine pH below 5.3 in the* Correspondence: suneth871@gmail.com
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distribution, and reproduction in any mediumpresence of systemic acidosis is the diagnostic hallmark of
type I or distal renal tubular acidosis.
Causes of distal renal tubular acidosis include auto-
immune diseases such as Sjögren's syndrome, systemic
lupus erythematosus and rheumatoid arthritis. Hereditary
distal tubular acidosis can occur due to mutations of
bicarbonate transporter called “band 3” of the basolateral
membranes of the intercalated cell which could be either
autosomal dominant (Western Europe) or recessive (south
east Asia)[3]. Cirrhosis, nephrocalcinosis, renal transplant-
ation, sickle cell anaemia, and obstructive uropathy are
other known aetiological factors. Drug induced renal
tubular acidosis can occur due to zoledronate, ifosfamide,
amphotericin B and lithium carbonate.
Hypercalciuria, hypocitraturia and elevated urinary pH
observed in distal renal tubular acidosis can lead to
nephrocalcinosis and may cause renal calculi, obstructiveentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Acid loading test
09.30 hrs
(immediately prior to acid loading)
At 15.30 hrs
Urine pH 6.91 6.86
Arterial PH 7.42 7.29
PCO2 34 21
HCO3 22 10.1
Results demonstrate the failure of urine to acidify in the presence of systemic
acidosis. Suggestive of distal renal tubular acidosis.
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endoscopic stone extraction [4].
Medullary nephrocalcinosis is the diffuse calcification
of the renal medulla due to deposition of calcium salts
within the parenchyma. Minute calcifications seen in
early stages may not be visible, but in later stages exten-
sive calcifications become visible in plain x ray films and
at times will give rise to renal colic and hydronephrosis
when dislodged calcific foci travel down the ureters.
Medullary sponge kidney, a developmental disorder
causing dilatation of the collecting ducts may independ-
ently cause both nephrocalcinosis and distal renal tubu-
lar acidosis with associated metabolic abnormalities.
This condition is characterized by diffuse dilatation of
precalyceal collecting ducts [5]. Associated biochemical
abnormalities include hypercalciuria, hypocitraturia and
defective urinary acidification giving rise to distal renal
tubular acidosis, nephrocalcinosis and increased risk or
urinary tract infections.
We describe a patient with nephrotic syndrome who is
currently in remission with steroid sparing immunomo-
dulator therapy who was found to have idiopathic
erythocytosis. Upon further investigation he was having
medullary nephrocalcinosis ultrasonically and type I
renal tubular acidosis.
Proposed mechanisms for erythrocytosis in patients
with renal tubular acidosis and nephrotic syndrome in-
clude increased erythropoietin secretion due to intra
renal hypoxia and increased secretion of interleukin 8
which in turn stimulate erythropoiesis. These mechan-
isms are yet to be confirmed biochemically [6].
Case presentation
A 22 year old Sri Lankan Sinhala male who was being
treated for steroid sensitive childhood nephrotic syn-
drome attended for routine clinic follow up.
There were no relapses for last two years and he did not
complain of frothuria or ankle oedema. His routine medi-
cation was continued and he was reviewed with a urine
full report and full blood count as he was plethoric.
The patient was diagnosed as having nephrotic syn-
drome at the age of two years and had responded to
steroids well. Despite good steroid response he contin-
ued to have frequent relapses as the follow up visits were
not regular due to family’s socioeconomic problems.
Renal biopsy was not performed earlier because of the
good steroid response and absence of active sediment in
urine. I.e. managed as minimal change disease. At the
age of twenty one years he was found to have steroid
induced osteoporosis, short stature and acne. He was
started on alendronate, vitamin D and calcium supple-
ments. Oral mycophenolate mofetil 250 mg twice a
day was started as a steroid sparing agent one year
previously.Full blood count revealed that he had polycythaemia
(Haemoglobin concentration of 17.8 g/L with a haem-
atocrit of 54%) repeated full blood counts confirmed the
presence of polycythaemia. Urine full report was nega-
tive for protein and red cells at this stage. An array of
investigations were performed to search for a cause of
the polycythaemia after the history excluded active or
passive smoking and the physical examination did not
show any murmurs suggestive of intra cardiac shunts or
intra abdominal masses. There was no evidence to sug-
gest a chronic lung disease on physical examination of
the respiratory system.
A transthoracic echocardiogram and a transoesopha-
geal echocardiogram did not reveal any shunts or
evidence of pulmonary hypertension. Arterial blood gas
analysis showed a metabolic acidosis but there was no
hypoxia. (PH-7.3, PCO2-31 mmHg, PO2-92 mmHg,
HCO3
- -15.3 mmol/l) Serum erythropoietin level was
normal at 6.2mIU/ml (3.7-29.5). Since there were no
secondary causes such as renal failure or diabetic ketoa-
cidosis which could explain the metabolic acidosis, renal
tubular acidosis was suspected. An acid loading test was
performed (Table 1) which showed failure of urinary
acidification in spite of systemic acidosis.
Urinary anion gap was positive favoring a diagnosis of
Distal or type I renal tubular acidosis (Table 2) Serum
potassium level remained persistently low. Patient was
diagnosed as having a hypokalaemic, hyperchloraemic
metabolic acidosis, most probably distal renal tubular
acidosis (RTA). On further investigation, he was found to
have medullary nephrocalcinosis ultrasonically but ab-
dominal X ray did not show any calcifications. Other rele-
vant investigation findings were as follows: serum calcium
2.6 mmol/l (2.1-2.55),serum magnesium 0.7 mmol/l(0.75-
1.2),serum Phosphate 1.4 mmol/l (0.8-1.5), urine Calcium/
Creatinine ratio of a fasting urine sample 0.7 (<0.4), Intact
PTH 17 pg/ml(10–65) ALP 201 IU/l, Free T4 1.39 ng/dl
(0.7-1.5), TSH 1.27uIU/ml(0.3-2.0), 24 Hr urine protein
excretion 0.6 g, Creatinine clearance 94 ml/min.
Bone marrow aspiration biopsy was compatible with
idiopathic erythrocytosis as JAK-2 V617F and Exon 12
mutations were negative.
The final diagnosis was steroid sensitive nephrotic syn-
drome, medullary nephrocalcinosis, type 1 distal renal
Table 2 Serum electrolytes, blood and urine pH and








Blood Anion gap 9.1
Urine Anion gap 2
Blood PH 7.33
Urine PH 7.34
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prescribed potassium citrate oral solution(potassium cit-
rate monohydrate 22 g/dl) two tablespoons twice a day.
He was also prescribed oral atorvastatin and alendro-
nate. An arterial blood gas analysis one month after
commencing therapy showed correction of the acidosis
with normal bicarbonate level. ABG after treatment was as
follows: PH- 7.40, PCO2 -39 mmHg, HCO3
– 24 mmol/l.
Since his follow up haematocrit was 52% venesection
was not performed. His renal functions and creatinine
clearance continued to be normal. Serum potassium level
was normalized at 4.2 mmol/l. Although his biochemical
abnormalities were thus corrected with therapy he was
advised to continue clinic follow up to detect progression
of nephrocalcinosis, renal impairment, relapses of neph-
rotic syndrome and monitoring of haematocrit to institute
venesection if and when appropriate.
Discussion
Although the association of medullary nephrocalcinosis
and type I hypokalaemic renal tubular acidosis is well
recognized [7,8] the association of these two clinical
entities with nephrotic syndrome and essential thrombo-
cytosis is rare.
Association of medullary nephrocalcinosis, distal renal
tubular acidosis and erythrocytosis is reported in a pa-
tient with nephrotic syndrome due to primary FSGS. In
this patient the proposed mechanisms for erythrocytosis
were increased erythropoietin secretion due to intrarenal
hypoxia and increased secretion of interleukin 8 which
in turn can stimulate bone marrow [6].
Balogun RA et al. describes medullary nephrocalcinosis,
distal renal tubular acidosis and proteinuria in a patient
with focal segmental glomerulosclerosis[9] but there was
no polycythaemia. Another report by Agroyannis et al.
describes a patient with medullary nephrocalcinosis, type I
distal renal tubular acidosis and erythocytosis [10] but this
patient did not have nephrotic syndrome or proteinuria.The association of minimal change disease, proteinuria
and erythrocytosis were observed in four previous
reports [11-14]. But nephrocalcinosis or renal tubular
acidosis were not described in these patients. Despite
the implication of increased erythropoietin levels in the
pathogenesis of erythrocytosis, erythropoietin level was
found to be normal in two of these reports while the
erythropoietin levels were not measured in other two.
The thrombocytosis was not due to renal overproduc-
tion of erythropoietin as the erythropoietin level was
normal in our patient. Therefore the other proposed
mechanism of erythocytosis i.e. increased renal produc-
tion of interleukin 8 has to be considered in this patient
but the measurement of interleukin levels was not done
in our patient due to resource constraints.
Treatment with potassium citrate to supplement po-
tassium and bicarbonate normalized the arterial pH,
bicarbonate level and potassium level. It is expected that
this treatment will prevent the development of renal
failure due to progression of nephrocalcinosis while con-
tinuation of mycophenolate mofetil will help to maintain
the remission of nephrotic syndrome. The management
of essential thrombocytosis will depend on the packed
cell volume and the symptoms during follow up visits.
If and when the patient develops further relapses of
nephrotic syndrome a renal biopsy has to be considered
to understand the pathology of the glomerular lesion so
as to direct therapy.
Conclusion
Distal renal tubular acidosis, nephrocalcinosis and poly-
cythaemia occurring in a patient with nephrotic syn-
drome is rare. Increased erythropoietin levels due to
intrarenal hypoxia and IL 8 mediated bone marrow
stimulation are the proposed mechanisms of erythrocy-
tosis in patients with nephrotic syndrome. Patients with
distal renal tubular acidosis should be treated preferen-
tially with potassium citrate.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for
review by the Series Editor of this journal.
Competing interests
The authors declare that they have no competing interests
Authors’ contributions
All four authors were involved in management of the patient. SK prepared
the manuscript. YU and DG provided input during manuscript preparation
and literature survey. HF critically appraised the manuscript and edited the
scientific data. All authors read and approved the final manuscript.
Authors’ information
SK is a postgraduate trainee in general medicine at National hospital of Sri
Lanka, which is the final tertiary care referral centre in Sri Lanka. YU and DG
Karunarathne et al. BMC Nephrology 2012, 13:66 Page 4 of 4
http://www.biomedcentral.com/1471-2369/13/66are senior registrars in medicine at the same institute. HF is a consultant
physician at the National hospital of Sri Lanka.
Acknowledgements
Dr Mrs Saroja Siriwardena(MBBS,MD) Consultant Chemical pathologist,
National hospital of Sri Lanka for the help with of acid loading test and PH
measurements.
Dr Mrs Bhaddika Jayaratne(MBBS,MD), Consultant haematologist, National
hospital of Sri Lanka for the help with bone marrow biopsy and investigation
of polycythaemia.
Received: 6 April 2012 Accepted: 9 July 2012
Published: 26 July 2012
References
1. Saha TC, Singh H: Minimal Change Disease: A Review. Southern Medical
Journal 2006, 99:1264–70.
2. Karet FE: Inherited distal renal tubular acidosis; Frontiers in nephrology.
J Am Soc Nephrol 2002, 13:2178–84.
3. Bruce LJ, Cope DL, Jones GK, Schofield AE, Burley M, Povey S, Unwin RJ,
Wrong O, Tanner MJ: Familial distal renal tubular acidosis is associated
with mutations in the red cell anion exchanger (Band 3, AE1) gene.
J Clin Invest 1997, 100(7):1693–707.
4. Arrabal-Polo MA, Arrabal-Martin M, Zuluaga-Gomez A: Nephrocalcinosis in
a patient with complete distal renal tubular acidosis. Acta clinica Belgica
2010, 65(4):281.
5. Carboni I, Andreucci E, Caruso MR, Ciccone R, Zuffardi O, Genuardi M, Pela I,
Giglio S: Medullary sponge kidney associated with primary distal renal
tubular acidosis and mutations of the H +−ATPase genes. Nephrol Dial
Transplant 2009, 24:2734–8.
6. Yadla M, Reddy S, SriramNaveen P, Krishnakishore C, Sainaresh VV,
Sivakumar V: An unusual association of primary focal and segmental
glomerulosclerosis, distal renal tubular acidosis and secondary
erythrocytosis. Saudi J Kidney Dis Transpl 2011, 22:1028–9.
7. Choi JS, Kim CS, Park JW, Bae EH, Ma SK, Kim SW: Incomplete Distal Renal
Tubular Acidosis with Nephrocalcinosis. Chonnam Med J 2011, 47(3):170–2.
8. Simoes A, Domingos F, Prata MM: Nephrocalcinosis induced by
furosemide in an adult patient with incomplete renal tubular acidosis.
Nephrol Dial Transplant 2001, 16:1073–4.
9. Balgoun RA, Adams MD, Palmisano J, Yamase H, Chughtai I, Kaplan AA:
Focal segmental glomerulosclerosis, proteinuria, and nephrocalcinosis
associated with renal tubular acidosis. Nephrol Dial Transplant 2002,
17:308–10.
10. Agroyannis B, Koutsikos D, Tzanatos-Exarchou H, Yatzidis H: Erythrocytosis
in type I renal tubular acidosis with nephrocalcinosis. Nephrol Dial
Transplant 1992, 7(4):365–6.
11. Lim CS, Jun KH, Kim YS, Ahn C, Han JS, Kim S, Lee JS: Secondary
polycythemia associated with idiopathic membranous nephropathy. Am
J Nephrol 2000, 20:344–6.
12. Ardites L, Mezzano S: Erythrocytosis associated to idiopathic membranous
nephropathy: Case report. Rev Med Chil 1992, 120:430–2.
13. Stack JI, Zabetaksis PM: Erythrocytosis associated with idiopathic
membranous glomerulopathy. Clin Nephrol 1979, 12:87–9.
14. Balal M, Seyrek N, Karayaylali I, Paydas S: A unique form of polycythemia
associated with minimal change disease. Med Princ Pract 2004, 13:366–8.
doi:10.1186/1471-2369-13-66
Cite this article as: Karunarathne et al.: Medullary nephrocalcinosis, distal
renal tubular acidosis and polycythaemia in a patient with nephrotic
syndrome. BMC Nephrology 2012 13:66.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
